Loading…
EOLS
Evolus, Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 30052C107
$7.41+0.14%Price as of Oct 23, 00:53 UTC · updated once a day, after the close
At a glance
Evolus, Inc. (EOLS) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Newport Beach, United States and has 353 employees. The company is worth $489.43M. Revenue was $297.18M in fiscal 2025, up 11.6% from the year before. It reported a net loss of $51.64M. The share price is 20.4% below its 52-week high of $9.31. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Israel Englander (Millennium Management), at $12.41M. In that quarter, 2 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $489.43M
- P/E
- —
- Forward P/E
- 25.3x
- P/B
- —
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$0.53
- ROE
- —
- Profit margin
- -10.85%
- Revenue growth
- +21.20%
- Beta
- 1.34
- 52-week high
- $9.31
- 52-week low
- $3.86
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +28.2% over 5Y.
today you would have $907.93▼ -9.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $6.65 | $11.04 | $10.53 | $7.51 | $6.51 | $3.36 | $12.17 | $11.90 | |
| P/S | 2.9x | 1.5x | 2.6x | 3.0x | 2.9x | 3.6x | 2.6x | 11.8x | — |
| P/B | 5.2x | — | 127.1x | — | 22.9x | 4.4x | — |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| DCTHDelcath Systems Inc | $14.08 | 1408.0x | 4.0x | 0.00% | 0.47% | $488.56M |
| EVOEvotec SE | $1.38 | — | 0.7x | 0.00% | -26.07% | $490.44M |
| FTHFaeth Therapeutics, Inc. | $18.80 | — | 2.8x | 0.00% | -195.26% | $485.8M |
| ARVNArvinas Inc | $7.72 |
About the company
- 353
- Newport Beach, United States